Previous Article | Next Article 
Journal of Bacteriology, November 1998, p. 5866-5874, Vol. 180, No. 22
0021-9193/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.
Escherichia coli DNA Topoisomerase I and Suppression
of Killing by Tn5 Transposase Overproduction:
Topoisomerase I Modulates Tn5 Transposition
Hesna
Yigit and
William S.
Reznikoff*
Department of Biochemistry, University of
Wisconsin
Madison, Madison, Wisconsin 53706
Received 18 June 1998/Accepted 11 September 1998
 |
ABSTRACT |
Tn5 transposase (Tnp) overproduction is lethal to
Escherichia coli. The overproduction causes cell
filamentation and abnormal chromosome segregation. Here we present
three lines of evidence strongly suggesting that Tnp overproduction
killing is due to titration of topoisomerase I. First, a suppressor
mutation of transposase overproduction killing, stkD10, is
localized in topA (the gene for topoisomerase I). The
stkD10 mutant has the following characteristics: first, it
has an increased abundance of topoisomerase I protein, the
topoisomerase I is defective for the DNA relaxation activity, and DNA
gyrase activity is reduced; second, the suppressor phenotype of a
second mutation localized in rpoH, stkA14 (H. Yigit and W. S. Reznikoff, J. Bacteriol. 179:1704-1713, 1997),
can be explained by an increase in topA expression; and
third, overexpression of wild-type topA partially
suppresses the killing. Finally, topoisomerase I was found to enhance
Tn5 transposition up to 30-fold in vivo.
 |
INTRODUCTION |
A transposon is a DNA sequence that
is able to insert itself into a new location in the genome without
requiring any sequence similarity within the target DNA. Transposons
cause genome rearrangements and are partially responsible for the
spread of bacterial antibiotic resistance, heavy metal resistance, and
increased tolerance to other deleterious agents (2).
Furthermore, bacterial transposition reactions serve as paradigms for
many gene transfer systems, including the processing and integration of
the human immunodeficiency virus type 1 provirus (10, 17,
31). Therefore, understanding the mechanism of transposition and
the role of host factors in this process is of considerable interest.
Nonetheless, the involvement of host factors both in transposition and
in retroviral integration is poorly understood.
Tn5 is a composite 5.8-kb transposon that contains 1.5-kb
inverted repeats (IS50R and IS50L) (3,
38). IS50R and IS50L each have 19-bp
repeats at their ends (the inside end and the outside end). These
sequences are recognized by the transposase and by host factors
involved in Tn5 transposition (3, 38). IS50R encodes two proteins that are important for
transposition: a 476-amino-acid-long cis-acting transposase
(Tnp) and a 421-amino-acid-long trans inhibitor (Inh)
(3, 38). The coding sequences of Tnp and Inh are identical
except that Inh lacks 55 N-terminal amino acids. IS50L
encodes two proteins, P3 and P4, that have no known function. P3 and P4
have the same coding sequences as Tnp and Inh, respectively, except
that both P3 and P4 lack 26 C-terminal amino acids. The central 2.75-kb
region of Tn5 contains three cotranscribed antibiotic
(kanamycin, bleomycin, and streptomycin) resistance genes. This region
does not have a known function in transposition (3, 38).
Transposition is a very rare event in many organisms due to tight
regulation whereby proteins (and/or functions) encoded by the
transposon itself and, in some cases, specific host factors play a role
(2, 38). For example, regulation of Tn5
transposition is dependent on the ratio between the two proteins, Tnp
and Inh, encoded by the element itself (in IS50R). The
Tn5 transposition frequency is also affected by a number of
host factors (3, 38). Integration host factor
(25), HU (3), DNA polymerase I (42),
DnaA (55), topoisomerase I (Topo I) (46), and DNA gyrase (21) are probably involved in the positive regulation of Tn5 transposition, while Dam DNA methylase
(56), Fis (51), and SulA (43) are
negative regulators. However, the underlying mechanisms of the majority
of these host factors in transposition remain to be determined.
Tn5 Tnp overproduction kills its host (52). It
has been shown that Tnp overproduction causes filament formation and
defective nucleoid segregation (52, 54). This phenomenon
could be a consequence of Tnp interaction with a host factor(s)
involved in transposition and a landmark event of the cell cycle, such as DNA segregation. Hence, Tnp overproduction killing could be used as
a tool to study the host factors involved in Tn5
transposition and a possible relationship between transposition and
chromosomal DNA segregation. Interestingly, Tnp overproduction killing
does not require an active transposase (52). Nevertheless,
analysis of N-terminal deletions of Tnp showed that deletion of the
first 3 or 11 amino acids (in the
3 or
11 mutant) from the N
terminus blocked killing while the same amount of Tnp accumulated in
the cell (52). The wild-type N terminus of Tnp must,
therefore, be critical for the cell killing phenotype.
To investigate the Tnp overproduction killing phenotype further, we
isolated and localized four host mutations, designated stk,
that suppress Tnp overproduction killing. These mutations were
localized to four discrete loci in the Escherichia coli
genome. The mutations map very close to genes known to be involved in cell division or DNA segregation: stkD10 at 28 min (shown in
this report to be in topA, encoding Topo I),
stkA14 at 76 min (in rpoH, encoding sigma 32 [54]), stkB33 at 85.5 min (near
xerC, uvrD, and recQ), and
stkC12 at 99.5 min (near dnaK, dnaJ,
dnaT, and dnaC) (52).
Previously we have studied stkA14 and localized this
mutation to rpoH. The sigma 32 mutation causes a
constitutive induction of heat shock protein levels, suggesting that an
induction of some sigma 32-programmed function(s) suppresses Tnp
overproduction killing. However, none of the well-known heat shock
functions appear to be involved in Tnp-associated killing
(54).
In this report, we present evidence that Tnp killing may be due to
titration of a specific host factor, DNA Topo I. The evidence comes
from a detailed characterization of a second stk mutant, stkD10, localized in topA. This mutation causes a
sixfold increase in Topo I abundance, and the mutant Topo I is only
partially active. The mutation causes an alteration in gyrase activity.
We also show that overproduction of wild-type Topo I partially
suppresses Tnp overproduction killing. Additional evidence was obtained
by a closer examination of stkA14. topA is transcribed at a
higher rate in stkA14, increasing Topo I abundance and
activity. These results suggest that the suppressor phenotype of this
mutation is probably due to an increase in Topo I abundance. Finally,
we present evidence (in partial agreement with Sternglanz et al. [46]) that DNA Topo I stimulates Tn5
transposition up to 30-fold in vivo. These results suggest that there
is a relationship between Tnp overproduction killing and Topo I.
 |
MATERIALS AND METHODS |
Strains and media.
The E. coli K-12 strains used
(Table 1) were grown in Luria broth (LB)
(41) or M9-glucose minimal salt medium (41)
containing all amino acids (except methionine and cysteine), each
supplemented with the following five vitamins at 0.01 mM:
p-aminobenzoic acid, p-dihydroxybenzoic acid,
p-hydroxybenzoic acid, pantothenate (calcium salt), and
thiamine (50). MgSO4 was added to 0.1 mM (final
concentration). LB plates contained 15 g of Bacto Agar per liter.
The antibiotic concentrations were as follows: chloramphenicol, 20 µg/ml; ampicillin, 100 µg/ml; kanamycin, 40 µg/ml; streptomycin,
100 µg/ml; nalidixic acid, 5 µg/ml; and tetracycline, 15 µg/ml.
Plasmids.
Most of the plasmids used in this study are
detailed in Fig. 1. pRZ4775 (encoding Tnp
under
pR control) was described by Weinreich
et al. (52). pRZ4787 was described by Weinreich
(53). pJW312-SalI, carrying topA
(encoding Topo I), was obtained from J. Wang (57). Cloning
vector pBII was supplied by A. Roca, and pBIP3, a cloning vector for
allele exchange experiments, was obtained from R. Maurer
(45).

View larger version (21K):
[in this window]
[in a new window]
|
FIG. 1.
Plasmids used in this study. pRZ4775, encoding wild-type
Tnp, does not have IS50 end sequences; pRZ4787 encodes Tnp
and contains a mini-Tn5 cassette; pRZ4775 does not express
Tn5 Inh; pRZ4787 expresses Tn5 Tnp and Inh;
pJW312-SalI encodes wild-type Topo I under
Plac control. OE, outside end; IE, inside end;
amp, ampicillin resistance; cam, chloramphenicol
resistance; kan, kanamycin resistance.
|
|
To perform allele replacement studies, a DNA fragment containing a
wild-type or mutant
topA gene was cloned as follows.
Wild-type
topA was cloned from pJW312-
SalI by
digestion with
HindIII-
PvuII
and ligation
into
HindIII-
SmaI sites of pBII to create
pRZ8860.
An
ApaI-
NotI fragment of pRZ8860
encoding wild-type
topA was then
cloned into the same sites
of pBIP3, yielding pRZ8861. The same
PCR product used for sequence
determination of the
stkD10 mutation
was cut with
PvuII-
AatII and then cloned into the same sites
of
pRZ8860 to generate pRZ8862. The
ApaI/
NotI
fragment containing
the
topA mutation of pRZ8862 was cloned
into the same sites of
pBIP3 to construct pRZ8864. The presence of the
mutation on pRZ8864
was confirmed by sequencing; then pRZ8864 (encoding
mutant
topA)
and pRZ8861 (encoding wild-type
topA) were used for the allele
replacement experiment to
test whether the mutation was sufficient
to confer suppression of
Tnp-associated killing in an otherwise
wild-type background
(MC1061).
topA allele replacement.
Mutant and wild-type
alleles of topA were subcloned into pBIP3 as described
above. The plasmids were then transferred into E. coli, and
a phagemid-based system for generating allele replacements was used as
described by Slater and Maurer (45). After presumed allele
exchange, about 200 to 250 individual colonies for each construct were
tested for the transposase overproduction phenotype at 42°C. pRZ4775
was used as the Tnp overproducer in these experiments.
35S labeling.
The cells were grown in M9-glucose
medium supplemented with all amino acids (except methionine and
cysteine) and five vitamins (50) at 32°C to an optical
density at 450 nm of 0.1. The cultures were then shifted to 42°C to
induce Tnp overproduction and, after a 1-h induction, pulse-labeled by
addition of 20 µCi of Trans35S-label mixture
(L-[35S]methionine and
L-[35S]cysteine; 1.146 Ci/mmol; ICN
Pharmaceuticals, Inc.) for 1 min with shaking; then the label was
chased by addition of 100 µl of methionine and cysteine (each at 10 mg/ml) for 1 min. The labeled sample was mixed with 110 µl of 50%
trichloroacetic acid (final trichloroacetic acid concentration of 5%).
For each sample, (5 × 105 cpm was analyzed by sodium
dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) on a 10% gel.
Western blot analysis of Topo I.
The overnight cultures of
the wild type (MDW505) and an stkD10-containing strain
(MDW565) were diluted 1:100 and grown to mid-log phase at 32°C (in
the absence of Tnp) or at 42°C (in the presence of Tnp). The cells
were harvested and sonicated (57). Equal amounts of proteins
from all samples were separated by SDS-PAGE (10% gel) and transferred
onto nitrocellulose filters (41). Western blots were
performed as instructed by the manufacturer (DuPont NEN). The antibody
for E. coli DNA Topo I was kindly supplied by J. Wang. The
Western blots were scanned in a densitometer, and the intensities of
the protein bands were quantitated by using ImageQuant and Excel programs.
Quantitation of Tnp overproduction killing by efficiency of
plating experiments.
After transformation of the plasmids (pRZ4775
and/or pJW312-SalI) into CaCl2-treated wild-type
(MC1061) competent cells (41), 12 to 20 individual colonies
for each sample were grown overnight at 32 or 37°C in LB containing
the appropriate antibiotic(s). Depending on the mode of regulating Tnp
synthesis and/or various host proteins in individual experiments,
dilutions of each sample were plated onto LB agar plates containing the
appropriate antibiotic(s) and the indicated concentrations of
isopropyl-
-D-thiogalactopyranoside (IPTG) (see figure
legends) or were incubated at 32 and 42°C. After 18 h, the
number of colonies formed in the presence of IPTG or at 42°C was
compared with the number in the uninduced control samples (grown in the
absence of IPTG or at 32°C).
PCR amplification and DNA sequencing of topA.
The
coding region topA and its control region were PCR amplified
in four partially overlapping fragments from both stkD10 and
wild-type (MC1061/pRZ4775) strains (see Fig. 4). The amplifications were carried out as described previously (54). The
PCR-amplified fragments were sequenced with dye termination (PRISM;
Applied Biosystems Inc.) by following the manufacturer's protocol. The sequencing reactions were analyzed at the University of Wisconsin Biotechnology Center. The presence of the mutation was confirmed by
using four separate PCR stocks: two different stocks of fragment 1, reading the noncoding strand; and two different stocks of fragment 2, reading the coding strand.
Protein assays.
Protein concentrations in cell extracts were
determined by the Bradford protein assay as described by Rossomando
(39).
Measurement of plasmid supercoiling.
To determine plasmid
DNA supercoiling in different stk mutants, the mutant and
wild-type strains were transformed with pUC19. Plasmid DNA was isolated
from overnight cultures by the alkaline method as described by Sambrook
et al. (41). The plasmid DNAs were analyzed by 1% agarose
gel electrophoresis in the presence of chloroquine (12 µg/ml).
Electrophoresis was carried out as described by Mizushima et al.
(30). The gels were stained with Syber Green II (Molecular
Probes) and analyzed with a FluorImager (Molecular Dynamics).
Topo I relaxation assay.
DNA Topo I relaxation activity was
assayed by the ability of a crude lysate prepared from the
stk and wild-type strains to relax supercoiled pUC19 DNA.
The plasmid DNA was prepared by CsCl purification as described
previously (41). The crude cell extract was prepared and the
relaxation assay was performed exactly as described by Zumstein and
Wang (57) except that the gels were stained with Syber Green
II (Molecular Probes) and were examined with a FluorImager (Molecular Dynamics).
DNA gyrase activity assay.
DNA gyrase activity was assayed
by the ability of a crude lysate prepared from the stk and
wild-type strains to introduce negative supercoils into relaxed pUC19
DNA in the presence of ATP. The same CsCl-purified pUC19 DNA as used in
the Topo I relaxation assays was used, except that the DNA was relaxed
by using wheat germ Topo I (Promega) as described by the manufacturer.
The gyrase activity tests were carried out as described by DiNardo et
al. (12), but with the same crude cell extracts as prepared
for the Topo I relaxation assay. The gels were examined after staining with Syber Green II with a FluorImager.
Primer extension.
The primer extensions were carried out as
described by Sambrook et al. (41). The gels were analyzed
with a PhosphorImager (Molecular Dynamics).
Transposition assays.
The
infection assays were carried
out as described by Sternglanz et al. (46) by using NK467.
The stains were modified to obtain isogenic backgrounds as follows. An
F' plasmid encoding lacIq from E. coli XL-Blue was introduced into RS2, SD7, and JTT1. Then
pJW312-SalI was introduced into the strains containing the F' plasmid. Six individual colonies for each strain (RS2F',
RS2F'/pJW312-SalI, SD7F', SD7F'/pJW312-SalI,
JTT1F', and JTT1F'/pJW312-SalI) were used in the
infection assay. RS2 and SD7 are topA10 strains with the
same genotype. To ensure that the observed results were not due to
genotypic changes during storage in a given strain, two different
topA strains were used. For the same reason, two different
topA strains (DM800 and a derivative) were also used. To
determine the transposition frequency under Topo I overproduction conditions, strains containing pJW312-SalI (the plasmid
encoding topA) were induced by using 0 to 0.2 mM IPTG. DM800
was transformed by pBAD33, so that the strain would contain
cam as a selective marker. The F' plasmid from E. coli from XL-Blue containing lacIq was
introduced yielding HY126. This strain is
topA. To obtain an isogenic topA+ strain, HY126 was then
transformed with pJW312-SalI, resulting in HY152. For each
strain, 16 individual colonies were used in the
infection assay.
 |
RESULTS |
Localization of stkD10 in topA. (i)
stkD10 causes a five- to six-fold increase in the abundance
of Topo I.
Previously four stk (suppressor of
transposase overproduction killing) mutations were isolated and located
to four discrete loci in the E. coli genome (53).
We studied these mutants further in order to investigate the host
factors involved in Tn5 transposition and its regulation.
This strategy might also help to determine whether there is a coupling
between Tn5 transposition or its regulation and chromosomal
DNA segregation, since Tnp overproduction causes defective DNA
segregation (52, 54).
The Hfr crossing and P1 mapping results localized the
stkD10
mutation to 28 min near
topA,
tonB,
terA, and
terD (
52). To
determine if
there was any change in protein synthesis or accumulation
levels in
stkD10-containing strains, we examined pulse-labeled
samples
and compared them to a wild-type strain and an
stkA14-containing
strain (Fig.
2). These results suggested that
stkD10 causes an
increased synthesis of a 90-kDa protein and
two proteins of approximately
100 kDa (Fig.
2, lane 2). Topo I is one
of the two proteins encoded
at the 28-min region, having a molecular
mass of close to 100
kDa. Thus, we suspected that the
stkD10
mutation may cause an
increase in
topA expression.

View larger version (32K):
[in this window]
[in a new window]
|
FIG. 2.
stkD10 causes higher levels of three proteins
of 90 to 100 kDa. Pulse-labeling and SDS-PAGE analyses were done as
described in Materials and Methods; autoradiograms of the gels are
presented. The autoradiograms were quantitated by densitometric
analyses. All strains used, wild type (wt), MDW565 (stkD10),
and MDW570 (stkA14), harbor pRZ4775 for Tnp overproduction.
The molecular masses were estimated from the known molecular masses of
Tnp (53 kDa), DnaK (70 kDa), and Hsp90. The gel shown is representative
of three individual experiments.
|
|
Next we examined by Western blot analysis whether one of the proteins
whose abundance was enhanced in
stkD10 was Topo I. The
Topo
I level in
stkD10 was compared to the wild-type (MC1061)
level both at 32°C in the absence of Tnp and at 42°C in the
presence
of Tnp. Equal amounts of protein from all samples were
examined
by Western blotting as described in Materials and Methods with
Topo I polyclonal antibodies. As shown in Fig.
3, two protein
bands were detected by the
Topo I antibody. We assume that one
band is full-length Topo I and the
second is a Topo I degradation
product. It is possible that these two
bands represent the two
~100-kDa bands seen to increase in the
stkD10 strain in Fig.
2.
Densitometric examination of the
Western blots shows that the
Topo I level in the
stkD10
mutant increased five- to sixfold at
32°C and fourfold at 42°C
(Fig.
3A and B, respectively). These
observations together with the
results of genetic mapping strongly
suggested that the
stkD10 mutation could be in the
topA regulatory
or coding region.

View larger version (25K):
[in this window]
[in a new window]
|
FIG. 3.
stkD10 mutation causes an increase in the
level of Topo I. Western blot analysis of cell extracts (32 µg of
total cell protein from each strain) prepared from wild-type (wt),
stkD10-containing, and stkA14-containing strains
was carried out as described in Materials and Methods with Topo I
antibodies, and the results were analyzed by densitometry. (A) Cell
extracts prepared from the wild-type strain and the
stkD10-containing strain at 32°C (in the absence of Tnp);
(B) cell extracts prepared from the wild-type strain and the
stkD10-containing strain at 42°C (in the presence of Tnp);
(C) cell extracts prepared from the stkA14-containing strain
at 42°C (in the presence of Tnp) and the stkA14-containing
strain at 32°C (in the absence of Tnp) and from the wild-type strain.
Comparable Western blot experiments were performed four times with
similar results.
|
|
(ii) stkD10 is located in topA (encoding
Topo I).
To determine the precise nature of the stkD10
mutation, we performed a sequence analysis of PCR-amplified
topA and its control region (both from an
stkD10-containing strain and from the parental wild-type
strain) as shown in Fig. 4. Sequencing of
these PCR-amplified fragments as described in Materials and Methods
revealed that the stkD10 mutation lies in topA
and results in an alanine-to-aspartate change at codon 118 (Fig. 4). We
confirmed this mutation by sequencing four individual PCR-amplified
stocks.

View larger version (24K):
[in this window]
[in a new window]
|
FIG. 4.
stkD10 is located in topA. The
topA region was PCR amplified and sequenced. The
stkD10 mutation was localized in the overlapping region of
fragments 1 and 2. The DNA and resulting amino acid sequence changes
are shown. The presence of a mutation was confirmed by analyzing four
different PCR stocks.
|
|
(iii) The topA mutation is sufficient for the
suppressor phenotype caused by the stkD10 mutation.
To
investigate whether the topA mutation by itself is
sufficient to suppress Tnp killing, we cloned wild-type topA
onto a phagemid, pBIP3, and inserted the mutation stkD10 as
described in Materials and Methods. The presence of the mutation was
confirmed by sequencing the phagemid clone. We used the allele
replacement method described by Slater and Maurer (45) to
introduce the topA mutation and, as a control, the wild-type
allele into a wild-type strain. After selecting appropriate
recombinants, we tested the isolates for the Tnp overproduction
killing. In four individual experiments in which 60 colonies were
tested each time, we found that when the topA mutation was
introduced into the wild-type strain, 38 (±2)% of the recombinants
became mutant (98% resistant to Tnp overproduction killing) while 62 (±2)% remained wild type (99% sensitive to Tnp overproduction
killing). When the wild-type clone was used, 98 (±2)% of the
recombinants remained wild type (99% sensitive for Tnp killing). These
results clearly show that the topA mutation is sufficient
for the suppression of Tnp killing in the stkD10-containing strain.
Properties of the mutant Topo I.
It is critical to examine the
effects of the mutation (stkD10) on Topo I activities in
order to understand the mechanism(s) for the suppression of Tnp
killing. In addition, an understanding of the properties of the Topo I
mutant may help elucidate a possible role for Topo I in Tn5 transposition.
(i) The mutant Topo I is defective for the DNA relaxation
activity.
Here, we present data showing that the stkD10
mutant version of Topo I is defective in its ability to relax
negatively supercoiled DNA. This conclusion was made by examining DNA
supercoiling of plasmid DNA isolated from the
stkD10-containing strain as well as testing the crude cell
extracts prepared from stkD10-containing and wild-type
strains for Topo I relaxation activity.
To examine DNA supercoiling in vivo in the
stkD10-containing
strain, we introduced pUC19 into the wild-type and
stkD10-containing
strains. The plasmid DNA was then isolated
and examined as described
in Materials and Methods. Figure
5 shows the resolution of the
topoisomers
of pUC19 isolated from
stkD10-containing and wild-type
bacteria, along with a densitometric graph of the gel. From these
data,
it is clear that plasmid DNA isolated from
stkD10 is more
negatively supercoiled than the same plasmid DNA isolated from
wild-type bacteria. This result suggests that mutant Topo I is
not
fully active in relaxation activity. The conclusion that DNA
isolated
from the
stkD10-containing strain was negatively supercoiled
arose from examining the resolution of topoisomers on gels containing
increasing concentrations of chloroquine in comparison with DNA
from
the wild-type strain; as the concentration of chloroquine
increased,
the negatively supercoiled DNA first became relaxed
and then became
positively supercoiled. For simplicity, we only
show one gel run at the
lowest chloroquine concentration indicating
the differences of DNA
supercoiling between the parental wild-type
strain and the
stkD10-containing strain.

View larger version (31K):
[in this window]
[in a new window]
|
FIG. 5.
stkD10 causes a decrease in Topo I relaxation
activity. Plasmid (pUC19) DNAs (2 µg) prepared from the wild-type
(wt) and stkD10-containing strains were electrophoresed in
the dark on a 1% agarose gel containing chloroquine (12 µg/ml). The
gel was stained and analyzed with a FluorImager (Molecular Dynamics).
Densitometric traces of the two lanes have been overlaid to show the
differences in DNA supercoiling.
|
|
We also used an in vitro Topo I relaxation assay (
57) to
study
stkD10 Topo I. The results shown in Fig.
6 are consistent
with the results of the
in vivo assay in that the mutant Topo
I is defective for relaxation
activity. This experiment was repeated
with three different crude cell
extracts where at least two individual
assays were performed per
preparation. This reduction in activity
in the
stkD10
extracts occurred despite the fact that the extracts
contained about
six times as much Topo I protein as the wild-type
extracts (Fig.
3A and
B).

View larger version (45K):
[in this window]
[in a new window]
|
FIG. 6.
stkD10 causes reduced Topo I relaxation
activity in vitro. Crude cell extracts (12 µg of crude cell
protein/reaction) prepared from wild-type (wt),
stkD10-containing and stkA14-containing strains
at 32°C were used to relax supercoiled pUC19 DNA (0.5 µg/reaction)
in vitro (57). The reactions were stopped (57)
and run on a 1% agarose gel. The gel was stained and analyzed with a
FluorImager (Molecular Dynamics). Densitometric traces of lanes 2 to 4 have been overlaid to show the differences in DNA supercoiling. Lane 1 contains the unreacted substrate DNA.
|
|
(ii) stkD10 confers a modest alteration in gyrase
activity.
The same crude cell extracts as used in the Topo I
assays were used to determine DNA gyrase activity in both
stkD10-containing and wild-type strains as described by
DiNardo et al. (12) (Fig. 7).
Quantitation of the gels indicated that DNA gyrase activity is reduced
four- to fivefold in the stkD10 mutant. This was calculated by measuring the percentage of relaxed pUC19 DNA converted into supercoiled DNA. A densitometric scan of an overlaid graph of the gel
is also shown in Fig. 7 to demonstrate the differences between the wild
type and the stk mutants.

View larger version (48K):
[in this window]
[in a new window]
|
FIG. 7.
stkD10 and stkA14 mutations cause
a modest alteration in gyrase activity. The same crude cell extracts
(12 µg of crude cell protein/reaction) as used for Fig. 6 were used
to measure gyrase activity in vitro. The percentage of pUC19 converted
to supercoiled DNA was measured (12). One percent agarose
gel electrophoresis was used, and the topoisomers were quantitated by
densitometry. Lanes: 1, control DNA; lanes 2 and 5, DNA treated with a
wild-type (wt) cell extract; 3 and 6, DNA treated with a cell extract
from the stkD10-containing strain; 4 and 7, DNA treated with
a cell extract from the stkA14-containing strain. The cell
extracts used in lanes 5 to 7 were fourfold diluted. Densitometric
traces of lanes 5 to 7 have been overlaid to show the differences in
the DNA supercoiling.
|
|
The reduced gyrase activity in
stkD10 could be explained by
a reduction in the expression of gyrase due to supercoiling-dependent
transcription regulation (
13).
Co-overproduction of wild-type Topo I partially suppresses Tnp
killing.
As mentioned above, there is in vivo evidence that Topo I
is increased in stkD10 and stkA14. Therefore, we
wanted to directly assess whether there is a relationship between
suppression of Tnp killing and an increase in Topo I quantities. To
test this possibility, we overproduced wild-type Topo I from
Plac by varying the concentration of IPTG (0 to
0.2 mM) to achieve different levels of expression while overproducing
Tnp under the control of lambda pR. The results
in Fig. 8 (averages from separate experiments [the differences between experiments were less than 2%])
show that Topo I co-overproduction suppresses Tnp killing 100-fold.
Although this level of suppression is substantially less than observed
for the stkA14 or stkD10 mutant, its occurrence supports a link between Tn5 Tnp killing and Topo I level.

View larger version (15K):
[in this window]
[in a new window]
|
FIG. 8.
Co-overproduction of wild-type Topo I suppresses Tnp
killing. Overnight cultures of MDW505/pJW312-SalI (+ Topo I)
and MDW505 (wild type) were diluted and plated on LB agar containing
various concentrations of IPTG (0 to 0.2 mM). After 18 to 14 h of
incubation at 32°C (no Tnp induction) and at 42°C (Tnp induction),
the colonies were counted and the percentage of CFU of the Tnp-induced
cultures relative to the uninduced cultures was calculated. In general,
the variation between different experiments for the same data points
was less than 1%. IPTG induces overproduction of Topo I. For instance,
Western blot analysis indicated a 10- to 12-fold increase in Topo I
when cells were grown in the presence of 0.06 mM IPTG.
|
|
Possible connection between stkA14 and
stkD10. (i) stkD10 and stkA14 both
lead to an increase in total topA mRNA.
Our previous
studies regarding stkA14 (in rpoH) suggested that
a sigma 32-regulated function other than induction of the well-known heat shock response proteins is responsible for the suppressor phenotype of stkA14. Since it has been shown that the P1
promoter of topA is sigma 32 dependent (23), we
examined Topo I RNA levels in an stkA14-containing strain
and an stkD10 containing strain. We used primer extension to
determine the levels of the topA transcripts and to
determine which promoters are responsible for the transcription in a
given strain. Equal amounts of total RNA were subjected to primer
extension (Fig. 9). The primer extension
studies show that in the stkA14-containing strain, 70% of the mRNA is
driven by the P1 promoter and the P1 RNA level is 10-fold higher than
in the wild-type strain (Fig. 9, lanes 1 and 3). In addition there was
two- to threefold increase from the P2 and P3 transcripts in the
stkA14-containing strain. The total topA mRNA
level in the stkD10-containing strain is about six- to
sevenfold increased (lanes 1 and 2) and is driven mostly from P2 and
P3. This could be explained by supercoiling-dependent regulation of
topA transcription (47, 48). This finding of
increased transcription of topA in the
stkD10-containing strain clearly explains the increased abundance of the mutant Topo I.

View larger version (39K):
[in this window]
[in a new window]
|
FIG. 9.
stkD10 (Topo I mutant) and stkA14
(sigma 32 mutant) alter topA mRNA levels. Primer extensions
were done with equal amounts of total RNA (2 µg) isolated from
wild-type (wt), stkD10-containing, and
stkA14-containing strains. The P4 promoter of
topA was used as an internal control. The gels were
quantitated with a PhosphorImager (Molecular Dynamics). P1, P2, P3, and
P4 indicate the positions of known topA transcripts. The
sequencing standard (G, A, T, and C) was a dideoxy primer extension
analysis of wild-type topA.
|
|
We also determined by Western blot analysis (Fig.
3C) that the Topo I
protein level is increased four- to fivefold in the
stkA14-containing
strain.
(ii) stkA14 causes an increase in both DNA gyrase and
Topo I activities.
Crude cell extracts prepared from the
stkA14-containing strain were used to determine Topo I
relaxation activity in vitro as described by Zumstein and Wang
(57) (Fig. 6, lane 3). Figure 6 also shows a densitometric
scan of lane 3. The results (averages from three separate experiments)
showed that there is about a four- to fivefold increase in the
topoisomerase relaxation activity in the stkA14-containing
strain. This result correlates with the Topo I protein level in that strain.
We also assayed gyrase activities in the crude cell extracts prepared
from the
stkA14-containing strain (Fig.
7, lanes 4 and
7).
As seen in lane 7,
stkA14 causes a modest (two- to
threefold)
increase in gyrase activity. This increase is most probably
in
response to the increase in Topo I activity (
13,
26).
These results suggest that the suppressor phenotypes of both
stkA14 and
stkD10 mutations are due to an
increase in the level
of Topo
I.
DNA topology is not critical for suppression.
If an alteration
of DNA topology is required to suppress Tnp overproduction killing, one
would expect to see a similar pattern of in vivo DNA topology in all
suppressor strains. We compared the in vivo plasmid DNA supercoiling in
all stk mutants that were isolated (52, 53) and
with that of the same plasmid DNAs isolated from the wild type.
The results clearly show that an alteration in DNA topology is not
required for the suppression of Tnp killing by
stk mutants.
Figure
10 shows the distribution of
topoisomers of plasmid DNAs
(pUC19) isolated from the wild type and
several
stk mutants. Of
the six mutant strains isolated,
only the
stkD10 mutant shows
a significant difference in DNA
supercoiling in vivo. These results
suggest that the suppression in
stkD10 is not due simply to an
alteration in DNA topology.

View larger version (107K):
[in this window]
[in a new window]
|
FIG. 10.
DNA topology is not critical for suppression. Plasmid
(pUC19) DNAs (0.5 to 2 µg) prepared from wild-type (wt) and
stk mutants were electrophoresed in the dark on a 1%
agarose gel containing chloroquine (12 µg/ml). The gel was stained
and analyzed with a FluorImager (Molecular Dynamics).
|
|
Topo I is a stimulator of Tn5 transposition.
If
Topo I plays an essential role in Tn5 transposition, then
topA-defective mutations should dramatically affect the
frequency of Tn5 transposition. Sternglanz et al.
(46) have reported that Tn5 transposition
decreases 70- to 90-fold in
topA strains and about
40-fold in topA10 strains. These strains were subsequently shown to have compensatory mutations in DNA gyrase. Therefore, we have
reexamined the effects of both
topA and topA10
on Tn5 transposition, using control strains that are as
nearly isogenic with the topA mutants as possible.
The frequency of Tn
5 transposition was tested in
topA strains and the isogenic
topA+
backgrounds (Table
2). The
topA strain HY126 showed a 10- to
30-fold decrease in
Tn
5 transposition frequency, but neither of
the
topA10 strains (HY116 and HY117) showed more than a 2-fold
difference in transposition frequency. Also, the frequency of
Tn
5 transposition did not change more than twofold in the
stkD10 mutant (data not shown). These results suggest that
the presence
of Topo I modulates Tn
5 transposition but it is
not absolutely
required; they also suggest that the presence of Topo I
but not
its relaxation activity is critical for its stimulation of
transposition.
We also examined Tn
5 transposition in a
strain overproducing wild-type
topA (data not shown). The
results suggested that overproduction
of
topA does not
further stimulate Tn
5 transposition.
 |
DISCUSSION |
Tnp killing is due to a titration of Topo I.
Detailed
examination of stkD10 and stkA14 mutants strongly
suggests that their suppressor phenotypes are due to an increase in
Topo I levels. stkD10 is mutated for topA. The
mutant Topo I has reduced relaxation activity (Fig. 5 and 6). This
reduction is likely responsible for the increase in topA
transcription, which then causes the increased level of Topo I. This is
due to the supercoiling-dependent regulation of topA
transcription (47, 48). The reduced DNA gyrase activity
(Fig. 7) in this mutant can be explained by the supercoiling-dependent
regulation of gyrase transcription (16, 26).
stkA14 is a sigma 32 mutant (
54). Recent studies
have suggested that some host factors other than the major heat shock
proteins
are also regulated by sigma 32 (
6,
7,
9,
36). It
has
been shown that
topA is one of the factors regulated by
sigma
32 (
23). Our studies demonstrate that
stkA14 results in elevated
levels of
topA mRNA
(Fig.
9) and Topo I protein (Fig.
3). As a
result, the activity of Topo
I in the
stkA14 mutant is increased
(Fig.
6). Probably in
response to an increase in Topo I activity,
the activity of DNA gyrase
is also increased in the
stkA14 mutant
(Fig.
7).
The above results strongly suggest that Tnp overproduction killing
could be overcome by an increase in the level of Topo I.
This model was
supported by the finding that Tnp overproduction
killing can be at
least partially suppressed by co-overproduction
of wild-type Topo I
(Fig.
8).
Overproduction of Topo I by itself is deleterious to the cell
(
49a). This might explain why only a partial recovery is
seen
when wild-type Topo I is co-overproduced. In the cases of
stkA14 and
stkD10, there may have been a
selection for achieving the
best level of Topo I synthesis to balance
these two
phenomena.
Altogether, these results strongly suggest that Tnp overproduction
killing is due to a titration of Topo I. From the studies
done by Wang
(
49) and DiNardo et al. (
12), it is clear that
Topo I is essential for cell survival. Consequently, a titration
of
Topo I by Tnp overproduction could be sufficient for the killing.
In
support of this conclusion, we have shown that Tnp and Topo
I copurify
and Tnp (but not

37, whose overproduction is not lethal)
can inhibit
Topo I in vitro (
54a).
Topo I modulates Tn5 transposition.
The
examination of stkD10 and stkA14 mutants
suggested that Topo I is involved in Tnp killing. Sternglanz et al.
(46) presented evidence that Topo I enhances Tn5
transposition; however, it was later suggested that these results were
due to the compensatory DNA gyrase mutants in these backgrounds
(3).
Here, we show that Topo I enhances Tn
5 transposition in
vivo. Unlike the case for DNA gyrase, in which the activity of gyrase
is required (
21), the presence but perhaps not the activity
of Topo I is required (Table
2). The conclusion that the activity
is
not critical comes from an examination of Tn
5 transposition
in the
stkD10- and
topA10-containing strains. The
stkD10-containing
strain is defective for Topo I relaxation
activity yet the frequency
of Tn
5 transposition is not
reduced but rather is enhanced two-
to threefold (Table
2).
topA10 has been extensively studied (
57).
This
allele encodes a Topo I that is defective for relaxation
activity but
is partially functional for Topo I-DNA covalent complex
formation. In a
topA strain, we found that the transposition
frequency is
decreased 10- to 30-fold (Table
2). Therefore, the
decrease in
Tn
5 transposition frequency correlates with the absence
of
Topo I protein. However, this decrease in the transposition
frequency
does not reflect the accumulation of more negatively
supercoiled DNA in
vivo. Additionally, the comparative analysis
of
topA and
topA/pJW312-
SalI strains clearly eliminates
the
possibility that the decrease in the transposition in the
topA background is due to a compensatory gyrase mutation
in this
background.
The results obtained here differ from those of Sternglanz et al.
(
46). In their study, a parental strain, wild-type for
both
gyrB and
topA, was used for comparison to a
topA strain
later shown to have a compensatory mutation
in
gyrB (
12). In
this comparison, an 80- to
90-fold depression in Tn
5 transposition
was observed in the
topA strain. Additionally, a 40-fold difference
was
observed in a
topA10 strain that was later shown to have a
compensatory mutation in
gyrB (
12). But the
results of Isberg
and Syvanen (
21), showing that the
activity of gyrase is a stimulator
for Tn
5 transposition,
suggest that the difference between our
results and the results of
Sternglanz et al. (
46) may be due
to a
gyrB or
gyrA mutation.
The involvement of Topo I in Tn
5 transposition could be
explained by one or more of the following models. (i) Topo I could
be
involved in target capture. Involvement of a secondary protein
encoded
by the transposon itself or by the host in target recognition
in
transposition and retroviral integration has been shown
(
10).
For example, it has been shown for bacteriophage Mu
transposition
that MuA (transposase) can select a target DNA by itself,
but
MuB bound DNAs are preferred targets (
28,
33). (ii)
Alternatively
Topo I could be involved in resolving the transposition
products
that are catenated. These models are currently under
investigation.
Tnp and Topo I copurify on Ni-nitrilotriacetic acid when Tnp is
histidine tagged (
54a). These recent studies strongly
suggest
that the involvement of Topo I in Tn
5 transposition
is through
a direct protein-protein interaction. In addition, we have
discovered
that Tnp inhibits Topo I relaxation activity in vitro as
well
as in vivo (
54a). Finally, we have recently discovered
that purified
Topo I stimulates Tn
5 transposition in a
defined in vitro system
and that this stimulation is only partially due
to its relaxation
activity (
54a).
Could Topo I titration by Tnp cause a defect in DNA
segregation?
The results presented here suggest that Tnp
overproduction killing could be due to a specific interaction between
Tnp and Topo I. We have also shown that Tnp overproduction causes
defective DNA segregation and an increase in anucleated cell formation
(52, 54). It has been shown that anucleated cells form in
par (gyrB [40] and
parC [1, 40]), mukA (19,
20), mukB (15, 34), minB
(6), and xerC (4, 5) mutants. These
gene products have been suggested to be involved in the bacterial
chromosome segregation processes. Recently it has been shown that
topA mutants can suppress mukB mutants
(44) and overproduction of topA can suppress
parC mutants (22, 35). These results suggest that Topo I could be involved in chromosomal DNA segregation, even though
studies of the four topoisomerases of E. coli have suggested that Topo I is incapable of catalyzing decatenation in vitro (18, 49).
Many of the processes involved in DNA segregation may be membrane
associated (
14,
20,
27,
40); 34% of Topo I (
29)
and 20% of Tnp (
54) are associated with the inner cell
membrane,
and Tnp membrane association correlates with the killing
effect
and the defective nucleoid segregation (
54).
Unfortunately,
neither the mechanism nor the role of Tnp-membrane or
Topo I-membrane
association is
known.
We hypothesize that the membrane-bound form of the Topo I is involved
in the chromosomal DNA segregation process. Perhaps
Tnp is localized in
the membrane via Topo I. This interaction
could then block proper DNA
segregation and result in cell killing
when Tnp is overproduced. The
possible benefit of this interaction
for transposition could be
explained in combination with the role
of Dam DNA methylase in
Tn
5 transposition. Dam DNA methylase regulates
the synthesis
of Tnp and (for IS
50) the transposition event itself,
suggesting that transposition preferentially takes place soon
after the
DNA replication fork passes when the donor DNA is hemimethylated
(
2,
38). This would allow the use of the sister chromosome
to fill in the gap left by the excision of a Tn
5. The
membrane-bound
Topo I-Tnp might delay the segregation process until
transposition
and the required repair in the donor are completed. This
could
be critical for the transposon to be able to be inherited in both
cells when it is located in the chromosomal DNA (
2,
38).
 |
ACKNOWLEDGMENTS |
This work was supported by NIH grant GM50692. H.Y. is a recipient
of a fellowship from the Turkish Ministry of National Education. W.S.R.
is the Evelyn Mercer Professor of Biochemistry and Molecular Biology.
J. Wang is thanked for supplying the Topo I antibody, strain DM800, and
pJW312-SalI. M. Cox is thanked for suggestions
regarding examination and quantitation of topoisomers. We specially
thank N. Gray and M. Weinreich for very helpful discussions and
comments on the manuscript. L. Barlow and T. Naumann are thanked for
comments on the manuscript. L. Barlow, N. Gray, and C. Luitjens are
specially thanked for proofreading the manuscript.
 |
FOOTNOTES |
*
Corresponding author. Mailing address: Department of
Biochemistry, 433 Babcock Dr., Madison, WI 53706-1544. Phone: (608)
262-3608. Fax: (608) 262-3453. E-mail:
reznikoff{at}biochem.wisc.edu.
 |
REFERENCES |
| 1.
|
Adams, D. E.,
E. M. Shekhtman,
E. L. Zechiedrich,
M. B. Schimid, and N. R. Cozzarelli.
1992.
The role of topoisomerase IV in partitioning bacterial replicons and the structure of catenated intermediates in DNA replication.
Cell
71:277-288[Medline].
|
| 2.
|
Berg, D. E.
1989.
Transposon Tn5, p. 185-210.
In
D. E. Berg, and M. M. Howe (ed.), Mobile DNA. American Society for Microbiology, Washington, D.C.
|
| 3.
|
Berg, D. E., and M. M. Howe (ed.).
1989.
Mobile DNA.
American Society for Microbiology, Washington, D.C.
|
| 4.
|
Blakely, G.,
S. Colloms,
G. May,
M. Burke, and D. Sherratt.
1991.
E. coli XerC recombinase is required for chromosomal segregation at cell division.
New Biol.
3:789-798[Medline].
|
| 5.
|
Blakely, G.,
G. May,
M. Burke,
R. McCulloch,
L. K. Arciszewska,
T. S. Lovett, and D. Sherratt.
1993.
Two related recombinases are required for site-specific recombination at dif and cer in E. coli K12.
Cell
75:351-336[Medline].
|
| 6.
|
Carranza, R. C.,
J. M. Hernandez,
J. M. Santos,
J. C. Dorranres,
V. C. De Sanchez, and C. Gomez-Eichelman.
1995.
Topoisomerase activity during the heat shock response in Escherichia coli.
J. Bacteriol.
177:3619-3622[Abstract/Free Full Text].
|
| 7.
|
Charpentier, B., and C. Branlant.
1994.
The Escherichia coli gapA gene is transcribed by the vegetative RNA polymerase holoenzyme E 70 and by the heat shock RNA polymerase E 32.
J. Bacteriol.
176:830-839[Abstract/Free Full Text].
|
| 9.
|
Chuang, S., and F. R. Blattner.
1993.
Characterization of twenty-six new heat shock genes of Escherichia coli.
J. Bacteriol.
175:5242-5252[Abstract/Free Full Text].
|
| 10.
|
Craig, N. L.
1997.
Target site selection in transposition.
Annu. Rev. Biochem.
66:437-474[Medline].
|
| 11.
|
DiGate, R. J., and K. J. Marians.
1988.
Identification of a potent decatenating enzyme from E. coli.
J. Biol. Chem.
263:13366-13373[Abstract/Free Full Text].
|
| 12.
|
DiNardo, S.,
K. A. Voelkel, and R. Sternglanz.
1982.
E. coli DNA topoisomerase I mutants have compensatory mutations in DNA gyrase genes.
Cell
31:43-51[Medline].
|
| 13.
|
DiNardo, S.,
K. A. Voelkel,
R. Sternglanz,
A. E. Reynolds, and A. Wright.
1983.
Escherichia coli DNA topoisomerase I mutants have compensatory mutations at or near DNA gyrase genes.
Cold Spring Harbor Symp. Quant. Biol.
47(pt. 2):779-784.
|
| 14.
|
Donachie, W. D.
1993.
The cell cycle of E. coli.
Annu. Rev. Microbiol.
47:199-230[Medline].
|
| 15.
|
Funnell, B., and L. Gagnier.
1995.
Partition of P1 plasmids in Escherichia coli mukB chromosomal partition mutants.
J. Bacteriol.
177:2381-2386[Abstract/Free Full Text].
|
| 16.
|
Gellert, M.,
R. Menzel,
K. Mizuuchi,
M. H. O'Dea, and D. I. Friedman.
1983.
Regulation of DNA supercoiling in E. coli.
Cold Spring Harbor Symp. Quant. Biol.
47(pt. 2):763-767.
|
| 17.
|
Grindley, N. D. F., and A. E. Leschziner.
1996.
DNA transposition: from a black box to a color monitor.
Cell
83:1063-1066.
|
| 18.
|
Hiasa, H.,
R. J. DiGate, and K. J. Marians.
1994.
Decatenating activity of E. coli DNA gyrase and topoisomerase I and III during oriC and pBR322 DNA replication in vitro.
J. Biol. Chem.
269:2093-2099[Abstract/Free Full Text].
|
| 19.
|
Hiraga, S.,
H. Niki,
T. Ogura,
C. Ichinose,
H. Mori,
B. Ezaki, and A. Jaffe.
1989.
Chromosome partitioning in Escherichia coli: novel mutants producing anucleated cells.
J. Bacteriol.
171:1496-1505[Abstract/Free Full Text].
|
| 20.
|
Hiraga, S.
1992.
Chromosome and plasmid partition in E. coli.
Annu. Rev. Biochem.
61:283-306[Medline].
|
| 21.
|
Isberg, R., and M. Syvanen.
1982.
DNA gyrase is a host factor required for transposition of Tn5.
Cell
30:9-18[Medline].
|
| 22.
|
Kato, J.,
Y. Nishimura,
R. Imamura,
H. Niki,
S. Hiraga, and S. Hideho.
1990.
New topoisomerase essential for chromosome segregation in E. coli.
Cell
63:393-404[Medline].
|
| 23.
|
Lesley, S. A.,
S. B. Jovanovich,
Y. C. Tse-Dinh, and R. R. Burgess.
1990.
Identification of a heat shock promoter in the topA gene of Escherichia coli.
J. Bacteriol.
172:6871-6874[Abstract/Free Full Text].
|
| 24.
|
Liu, L. F., and J. C. Wang.
1979.
Interaction between DNA and E. coli DNA topoisomerase I.
J. Biol. Chem.
254:11082-11088[Free Full Text].
|
| 25.
|
Markis, J. P.,
P. L. Nordman, and W. S. Reznikoff.
1990.
Integration host factor plays a role in IS50 and Tn5 transposition.
J. Bacteriol.
172:1368-1373[Abstract/Free Full Text].
|
| 26.
|
Menzel, R., and M. Gellert.
1983.
Regulation of the genes for E. coli: homeostatic control of DNA supercoiling.
Cell
34:105-113[Medline].
|
| 27.
|
Miller, W. G., and R. W. Simons.
1993.
Chromosomal supercoiling in E. coli.
Mol. Microbiol.
10:675-684[Medline].
|
| 28.
|
Millner, A., and G. Choconas.
1998.
Disruption of target DNA binding in Mu DNA transposition by alteration of position 99 in the MuB protein.
J. Mol. Biol.
275:233-243[Medline].
|
| 29.
|
Mizushima, T.,
S. Natori, and K. Sekimizu.
1992.
Inhibition of E. coli DNA topoisomerase I activity by phospholipids.
Biochem. J.
285:503-506.
|
| 30.
|
Mizushima, T.,
S. Natori, and K. Sekimizu.
1993.
Relaxation of supercoiled DNA associated with induction of heat shock proteins in E. coli.
Mol. Gen. Genet.
238:1-5[Medline].
|
| 31.
|
Mizuuchi, K.
1992.
Transpositional recombination: mechanistic insights from studies of Mu and other elements.
Annu. Rev. Biochem.
61:1011-1051[Medline].
|
| 32.
|
Mulder, E.,
M. El'Bouhali,
E. Pas, and C. L. Woldringh.
1990.
The E. coli minB mutation resembles gyrB in defective nucleoid segregation and decreased negative supercoiling of plasmids.
Mol. Gen. Genet.
221:87-93[Medline].
|
| 33.
|
Naigamwalla, D. Z., and G. Chaconas.
1997.
A new step of Mu DNA transposition intermediates: alternate pathways of target capture preceding strand transfer.
EMBO J.
16:5227-5234[Medline].
|
| 34.
|
Niki, H.,
A. Jaffe,
R. Imamura,
T. Ogura, and S. Hiraga.
1991.
The new gene mukB codes for a 177 kDa protein with coiled-coil domains involved in chromosome partitioning of E. coli.
EMBO J.
10:183-193[Medline].
|
| 35.
|
Nishimura, A.
1989.
A new gene controlling the frequency of cell division per round of DNA replication in E. coli.
Mol. Gen. Genet.
215:286-293[Medline].
|
| 36.
|
Ogata, Y.,
T. Mizushima,
K. Kataoka,
T. Miki, and K. Sekimizu.
1994.
Identification of DNA topoisomerases involved in immediate and transient DNA relaxation induced by heat shock in E. coli.
Mol. Gen. Genet.
244:451-455[Medline].
|
| 37.
|
Ogden, G. B.,
M. J. Pratt, and M. Schaechter.
1988.
The replicative origin of the E. coli chromosome binds to cell membranes only when hemimethylated.
Cell
54:127-135[Medline].
|
| 38.
|
Reznikoff, W. S.
1993.
The Tn5 transposon.
Annu. Rev. Microbiol.
47:945-963[Medline].
|
| 39.
|
Rossomando, E. F.
1990.
Measurement of enzyme activity.
Methods Enzymol.
182:38-68[Medline].
|
| 40.
|
Rothfield, L. I.
1994.
Bacterial chromosome segregation.
Cell
77:963-966[Medline].
|
| 41.
|
Sambrook, J.,
E. F. Fritsch, and T. Maniatis.
1989.
Molecular cloning: a laboratory manual, 2nd ed.
Cold Spring Harbor Laboratory Press, Cold Spring Harbor, N.Y.
|
| 42.
|
Sasakawa, C.,
Y. Uno, and M. Yoshikawa.
1981.
The requirement for both DNA polymerase and 5' to 3' exonuclease activities of DNA polymerase I during Tn5 transposition.
Mol. Gen. Genet.
182:19-24[Medline].
|
| 43.
|
Sasakawa, C.,
Y. Uno, and M. Yoshikawa.
1987.
lon-sulA regulatory function affects the efficiency of transposition of Tn5 from lambda b221 cI857 Pam Oam to the chromosome.
Biochem. Biophys. Res. Commun.
142:879-884[Medline].
|
| 44.
|
Sawitzke, J., and S. J. Austin.
1997.
Genetic links between E. coli chromosome segregation and P1 plasmid partition, p. 83.
In
Molecular genetics of bacteria and phages. University of Wisconsin, Madison, Wis.
|
| 45.
|
Slater, S., and R. Maurer.
1993.
Simple phagemid-based system for generating allele replacements in Escherichia coli.
J. Bacteriol.
175:4260-4262[Abstract/Free Full Text].
|
| 46.
|
Sternglanz, R.,
S. DiNardo,
K. A. Voelker,
Y. Nishimura,
Y. Hirota,
K. Baecherer,
L. Zumstein, and J. C. Wang.
1981.
Mutations in the gene coding for E. coli DNA topoisomerase I affect transcription and transposition.
Proc. Natl. Acad. Sci. USA
78:2747-2751[Abstract/Free Full Text].
|
| 47.
|
Tse-Dinh, Y.
1985.
Regulation of the E. coli DNA topoisomerase I by DNA supercoiling.
Nucleic Acids Res.
13:4751-4763[Abstract/Free Full Text].
|
| 48.
|
Tse-Dinh, Y., and R. K. Beran.
1988.
Multiple promoters for transcription of the E. coli DNA topoisomerase I gene and their regulation by DNA supercoiling.
J. Mol. Biol.
202:735-742[Medline].
|
| 49.
|
Wang, J. C.
1996.
DNA topoisomerases.
Annu. Rev. Biochem.
65:635-692[Medline].
|
| 49a.
| Wang, J. C. Personal communication.
|
| 50.
|
Wanner, B. L.,
R. Kodaira, and F. C. Neidhardt.
1977.
Physiological regulation of a decontrolled lac operon.
J. Bacteriol.
130:212-222[Abstract/Free Full Text].
|
| 51.
|
Weinreich, M. D., and W. S. Reznikoff.
1992.
Fis plays a role in Tn5 and IS50 transposition.
J. Bacteriol.
174:4530-4537[Abstract/Free Full Text].
|
| 52.
|
Weinreich, M. D.,
H. Yigit, and W. S. Reznikoff.
1994.
Overexpression of the Tn5 transposase in Escherichia coli results in filamentation, aberrant nucleoid segregation, and cell death: analysis of E. coli and transposase suppressor mutations.
J. Bacteriol.
176:5494-5504[Abstract/Free Full Text].
|
| 53.
|
Weinreich, M. D.
1993.
Ph.D. thesis.
University of Wisconsin, Madison, Wis.
|
| 53a.
|
Wingfield, P. T.,
D. W. Speicher,
H. L. Ploegh,
B. M. Dunn, and J. E. Coligan (ed.).
1995.
Current protocols in protein science.
John Wiley & Sons, New York, N.Y.
|
| 54.
|
Yigit, H., and W. S. Reznikoff.
1997.
Examination of the Tn5 transposase overproduction phenotype in Escherichia coli and localization of a suppressor of transposase overproduction killing that is an allele of rpoH.
J. Bacteriol.
179:1704-1713[Abstract/Free Full Text].
|
| 54a.
| Yigit, H., and W. S. Reznikoff. Submitted for
publication.
|
| 55.
|
Yin, J. P., and W. S. Reznikoff.
1987.
dnaA, an essential host gene and Tn5 transposition.
J. Bacteriol.
169:4637-4645[Abstract/Free Full Text].
|
| 56.
|
Yin, J. P.,
M. P. Kreps, and W. S. Reznikoff.
1988.
The effect of Dam methylation on Tn5 transposition.
J. Bacteriol.
169:4637-4645.
|
| 57.
|
Zumstein, L., and J. C. Wang.
1986.
Probing the structural domains and function in vivo of E. coli DNA topoisomerase I by mutagenesis.
J. Mol. Biol.
191:333-340[Medline].
|
Journal of Bacteriology, November 1998, p. 5866-5874, Vol. 180, No. 22
0021-9193/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
-
Tse-Dinh, Y.-C.
(2009). Bacterial topoisomerase I as a target for discovery of antibacterial compounds. Nucleic Acids Res
37: 731-737
[Abstract]
[Full Text]
-
Yigit, H., Reznikoff, W. S.
(1999). Escherichia coli DNA Topoisomerase I Copurifies with Tn5 Transposase, and Tn5 Transposase Inhibits Topoisomerase I. J. Bacteriol.
181: 3185-3192
[Abstract]
[Full Text]